How It’s Used
The FDA comes up in nearly every conversation about kratom regulation, safety, and market access. Vendors must navigate FDA enforcement carefully, marketing kratom with health or therapeutic claims can trigger warning letters and enforcement actions.
For consumers, the FDA’s position is a data point, not the final word. The agency’s concerns are worth taking seriously, but they exist alongside a growing body of independent research, centuries of traditional use, and the practical experience of millions of consumers. The regulatory gap the FDA has left is being filled by the AKA‘s GMP certification program and state-level KCPA legislation, both of which provide the safety standards the FDA has declined to create.
